Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review

by Francesco Spagnolo, Andrea Boutros, Federica Cecchi, Elena Croce, Enrica Teresa Tanda, Paola Queirolo
Published 2021-04-01

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient

by Andrea Boutros, Andrea Boutros, Chiara Schiavi, Federica Cecchi, Francesco Spagnolo, Antonio Guadagno, Enrica Teresa Tanda, Francesca Giusti, Giuseppe Murdaca, Paola Queirolo
Published 2020-11-01

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma

by Andrea Boutros, Andrea Boutros, Federica Cecchi, Enrica Teresa Tanda, Enrica Teresa Tanda, Elena Croce, Elena Croce, Riccardo Gili, Riccardo Gili, Luca Arecco, Luca Arecco, Francesco Spagnolo, Paola Queirolo
Published 2021-08-01

Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?

by Enrica Teresa Tanda, Enrica Teresa Tanda, Agostina Lagodin d’Amato, Agostina Lagodin d’Amato, Giovanni Rossi, Giovanni Rossi, Elena Croce, Elena Croce, Andrea Boutros, Andrea Boutros, Federica Cecchi, Francesco Spagnolo, Paola Queirolo
Published 2021-09-01

Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, <i>ATM, BAP1,</i> and <i>POT1</i>

by Lorenza Pastorino, Virginia Andreotti, Bruna Dalmasso, Irene Vanni, Giulia Ciccarese, Mario Mandalà, Giuseppe Spadola, Maria Antonietta Pizzichetta, Giovanni Ponti, Maria Grazia Tibiletti, Elena Sala, Maurizio Genuardi, Pietro Chiurazzi, Gabriele Maccanti, Siranoush Manoukian, Serena Sestini, Rita Danesi, Valentina Zampiga, Roberta La Starza, Ignazio Stanganelli, Alberto Ballestrero, Luca Mastracci, Federica Grillo, Stefania Sciallero, Federica Cecchi, Enrica Teresa Tanda, Francesco Spagnolo, Paola Queirolo, Italian Melanoma Intergroup (IMI), Alisa M. Goldstein, William Bruno, Paola Ghiorzo
Published 2020-04-01